Zhang P - Search Results

1

Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial.

Zhang P, Shi S, Xu J, Chen Z, Song L, Zhang X, Cheng Y, Zhang Y, Ye F, Li Z, Yin F, Ji D, Gao H, Li Y, Chen W, Yang M, Weng D, Wu C, Ma Y, Sheng W, Zhao Y, Yin X, Shen W, Su W, Shi M, Fan S, Tan P, Xu Q, Lu M, Shen L. Zhang P, et al. Among authors: zhang x, zhang y. Eur J Cancer. 2024 Mar;199:113539. doi: 10.1016/j.ejca.2024.113539. Epub 2024 Jan 15. Eur J Cancer. 2024. PMID: 38237373 Free article. Clinical Trial.

2

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm.

Zhang P, Li Z, Li J, Li J, Zhang X, Lu Z, Sun Y, Li Y, Zhou J, Wang X, Peng Z, Shen L, Lu M. Zhang P, et al. Among authors: zhang x. Cancer Med. 2021 Jul;10(14):4855-4863. doi: 10.1002/cam4.4031. Epub 2021 Jun 10. Cancer Med. 2021. PMID: 34109756 Free PMC article.

3

Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.

Zhang P, Chen Z, Shi S, Li Z, Ye F, Song L, Zhang Y, Yin F, Zhang X, Xu J, Cheng Y, Su W, Shi M, Fan S, Tan P, Zhong C, Lu M, Shen L. Zhang P, et al. Among authors: zhang x, zhang y. Cancer Immunol Immunother. 2024 May 7;73(7):119. doi: 10.1007/s00262-024-03677-7. Cancer Immunol Immunother. 2024. PMID: 38713205 Free PMC article. Clinical Trial.

4

Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials.

Qi C, Zhang P, Liu C, Zhang J, Zhou J, Yuan J, Liu D, Zhang M, Gong J, Wang X, Li J, Zhang X, Li N, Peng X, Liu Z, Yuan D, Baffa R, Wang Y, Shen L. Qi C, et al. Among authors: zhang m, zhang p, zhang j, zhang x. J Clin Oncol. 2024 May 24:JCO2302314. doi: 10.1200/JCO.23.02314. Online ahead of print. J Clin Oncol. 2024. PMID: 38788174

5

Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.

Zhang P, Ma Y, Lv C, Huang M, Li M, Dong B, Liu X, An G, Zhang W, Zhang J, Zhang L, Zhang S, Yang Y. Zhang P, et al. Among authors: zhang l, zhang s, zhang w, zhang j. Cancer Sci. 2016 Nov;107(11):1563-1571. doi: 10.1111/cas.13072. Cancer Sci. 2016. PMID: 27581532 Free PMC article.

6

Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer.

Zhang P, Ma M, Nie J, Dai L, Hu W, Zhang J, Wu D, Chen X, Ma X, Tian G, Han S, Long J, Wang Y, Zhang Z, Hao Q, Fang J. Zhang P, et al. Among authors: zhang j, zhang z. Heliyon. 2024 Feb 11;10(4):e26026. doi: 10.1016/j.heliyon.2024.e26026. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38390071 Free PMC article.

7

Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study.

Huang Z, Li S, Yang X, Lu F, Huang M, Zhang S, Xiong Y, Zhang P, Si J, Ma Y, Yang Y. Huang Z, et al. Among authors: zhang s, zhang p. Cancer Manag Res. 2019 Feb 8;11:1299-1308. doi: 10.2147/CMAR.S195355. eCollection 2019. Cancer Manag Res. 2019. PMID: 30799956 Free PMC article.

8

Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients.

Ma Y, Zhang P, An G, Zhang X, Zhang L, Si J, Zhang J, Yang Y. Ma Y, et al. Among authors: zhang l, zhang p, zhang j, zhang x. Med Sci Monit. 2016 Oct 27;22:4017-4025. doi: 10.12659/msm.900661. Med Sci Monit. 2016. PMID: 27784882 Free PMC article.

9

Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.

Zhang P, Kang B, Xie G, Li S, Gu Y, Shen Y, Zhao X, Ma Y, Li F, Si J, Wang J, Chen J, Yang H, Xu X, Yang Y. Zhang P, et al. Cancer Lett. 2019 Feb 1;442:53-67. doi: 10.1016/j.canlet.2018.10.035. Epub 2018 Oct 27. Cancer Lett. 2019. PMID: 30391781 Free article.

10

Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer.

Ma Y, Li M, Si J, Xiong Y, Lu F, Zhang J, Zhang L, Zhang P, Yang Y. Ma Y, et al. Among authors: zhang l, zhang p, zhang j. Int J Oncol. 2016 Jun;48(6):2349-58. doi: 10.3892/ijo.2016.3464. Epub 2016 Mar 30. Int J Oncol. 2016. PMID: 27035162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29,168 results

Search Page